Aug 2026· Frontiers in Molecular Biosciences· Vol 13· 0 citations· 327 references
Medicine
TL;DR
How dysfunction in NMD pathway components—specifically core degradation factors, the exon junction complex, and neuron-specific splicing regulators—underpins an extensive array of neurodevelopmental disorders (NDDs) is examined.
Abstract
Nonsense-mediated mRNA decay (NMD) is a basic post-transcriptional mechanism ensuring the fidelity of many biological processes including brain development. Together with alternative splicing, it regulates the inclusion of poison exons. NMD is involved in the control of multiple processes during brain development such as neural progenitor proliferation and differentiation, neuronal migration, axonal guidance, and synaptic plasticity. Under physiological conditions, this mechanism safeguards neuronal identity and the functional maturation of the brain. When disrupted, the consequences range from structural cerebral anomalies to cognitive impairment and epilepsy. This review examines NMD-mediated regulatory mechanisms across different stages of brain development. Special emphasis is placed on how dysfunction in NMD pathway components—specifically core degradation factors, the exon junction complex, and neuron-specific splicing regulators—underpins an extensive array of neurodevelopmental disorders (NDDs). Furthermore, we delineate the relationship between the position of a premature termination codon (PTC) within a transcript and the resulting molecular outcome. While the degradation of aberrant mRNAs often leads to haploinsufficiency, their escape from NMD might result in the accumulation of truncated proteins with dominant-negative effects, thereby causing specific clinical phenotypes in affected patients. Elucidating these mechanisms is essential for both the interpretation of variant pathogenicity and the development of targeted therapeutic strategies.
Current evidence on the RNA regulatory networks in PD is examined, highlighting the role of transcript isoforms and RBPs in neuronal dysfunction and emerging data suggest that dysregulation of RNA binding proteins (RBPs) may influence RNA processing in PD.
Maria Giusy Bruno, G. Menichetti, Angela Valentino et al.· Genes· 0 citations
Using neural differentiation of human induced pluripotent stem cells, it is shown that the A3SS transcript is abundant in neural progenitors, astrocytes, microglia and immature neurons, with minimal presence in mature neurons, implying that SSOs targeting A3SS might lack therapeutic efficacy to rescue the neuronal phen...
J. A. Kamp, K. N. Wijnant, N. Maas et al.· bioRxiv· 0 citations
It is found that the ablation of Mettl14 in postmitotic neurons leads to impaired axonal projection during corticogenesis, and the authors show that m6A RNA marks recruit YTHDF2-associated transport machinery that favors transport over degradation, localizing selected mRNAs to neurites to promote cortical axon projecti...
Bonsang Koo, Ajeet Kumar, H. Hwang et al.· Nature Communications· 0 citations
A homozygous synonymous NPR2 variant is identified in an individual with AMDM and aberrant splicing induced by a synonymous variant as a disease-causing mechanism affecting a core developmental signaling pathway is established.
N. B. Acikgoz, Hasan Basri Kılıç, Gizem Urel Demir et al.· Differentiation; research in...· 0 citations
It is shown that PTC location critically determines not only NMD efficiency and its variability across cells, but also the spectrum of resulting protein products, including truncated proteins arising from premature termination, full-length proteins generated through translational readthrough, and N-terminally truncated...
This review critically synthesizes existing evidence and thoroughly assesses the unique molecular fingerprints of ADAR dysregulation across several CNS disorders, emphasizing recurring themes such as Alu RNA hypo-editing, induction of innate immunity, and GRIA2 editing, which can cause excitotoxicity.